Developer docs
API playgroundTry for free, no card

Search company profiles

Westminster Pharmaceuticals

Full company profile

uuid0027bwe

Namestring
Westminster Pharmaceuticals
Legal namestring
Westminster Pharmaceuticals
Websiteurl
wprx.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Westminster Pharmaceuticals (operating commercially as WPRX) is a privately held B2B generic pharmaceutical distributor founded in 2012 and headquartered in Nashville, Tennessee, with a sales office in Tampa, Florida. The company distributes more than 100 generic pharmaceutical products across three categories (prescription drugs, over-the-counter medications, and dietary supplements) to retail and hospital pharmacies, wholesalers, distributors, and manufacturers across the United States. Named enterprise customers include Walgreens and Rite-Aid, and the company manages 180 Medicaid program contracts across all 50 states. Approximately 90 percent of products are manufactured domestically in the United States, which the company positions as a supply chain and quality differentiator against generic competitors reliant on offshore production.

The business operates a relationship-driven, sales-led go-to-market with named contacts for business development, sales, customer service, regulatory affairs, and pharmacovigilance. Underlying technology centers on SAP/ATTP serialization software for unit-level product tracking and DSCSA compliance (met ahead of the November 2024 stabilization deadline), supplemented by predictive analytics for demand forecasting. Fulfillment runs through Direct Customer Solutions (formerly R&S Solutions), a 230,000 sq ft third-party logistics facility in West Tennessee with robotic handling, refrigeration, and secured storage capabilities. The company does not sell directly to consumers and operates a quote-based B2B pricing model with no publicly disclosed pricing.

Westminster generates revenue from the margin between acquisition and sale prices on distributed generic pharmaceuticals (transaction-fee model), supplemented by manufacturer-side distribution partnerships. The company has executed strategic partnerships with OEP Pharma (single-source miglitol distribution) and the USF Taneja College of Pharmacy (industry scholarship), and was recognized with the USF Fast 56 Class of 2021 award and an EY Entrepreneur of the Year 2022 nomination for CEO Louis Sanchez. Under Sanchez's ownership since 2016, the company has reported an average of 400 percent year-over-year growth, operating with a small team of 11-50 employees.

Short descriptiontext

Westminster Pharmaceuticals is a privately held US generic drug distributor (WPRX) serving retail and hospital pharmacies, wholesalers, and manufacturers with 100-plus prescription, OTC, and dietary supplement products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNashville, United States
HQ citystring
Nashville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceutical distribution, pharmaceutical wholesale supply, generic drug wholesale, pharmaceutical logistics services, generic medications supplier
Industry1 code
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Distribution
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Generic Pharmaceutical Distribution
TypeTransaction Fee
Description

Westminster Pharmaceuticals generates revenue by distributing generic drugs to pharmacies, hospitals, and trusted wholesalers and distributors. The company acquires high-quality generic drugs within high-demand categories and distributes them through its partner network, with revenue derived from the margin between acquisition and sale prices to B2B customers.

wprx.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1WPRX
Description

Primary commercial brand name and website domain for Westminster Pharmaceuticals generic pharmaceutical distribution.

wprx.com
Core offering1 text field

Westminster Pharmaceuticals distributes generic pharmaceutical products to retail pharmacies, hospital pharmacies, and authorized wholesalers and distributors across the United States. Its product portfolio spans prescription generic drugs (cardiovascular, neurological, psychiatric, anti-infective, metabolic, and other therapeutic categories), OTC products, and dietary supplements. Distribution and supply-chain operations are supported by a preferred 3PL partner and SAP/ATTP serialization technology for DSCSA-compliant traceability.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 400% average annual growth since 2016 new ownership
+2 more records
Product overview1 text field

Westminster Pharmaceuticals (WPRX) is a generic pharmaceutical distributor providing timely access to high-quality generic drugs at affordable prices. The company's product portfolio consists of three main categories distributed through pharmacies, hospitals, and wholesalers: Prescription Generic Drugs (including extended-release formulations, injectables, and oral solutions across cardiovascular, neurological, psychiatric, anti-infective, metabolic, and other therapeutic categories), OTC Products (including analgesics, cold/cough medications, dermatological products, dental care products, and mineral supplements), and Dietary Supplements (including prenatal vitamins, iron supplements, and phosphorus supplements for dialysis patients). The portfolio includes branded product lines such as WesTussin cough liquids, WesTab/WesCaps/WesGel/WesNate prenatal supplements, and Wes-Phos phosphorus supplements. Nearly 90% of products are manufactured in the United States.

Product and service4 records
1Prescription Generic Drugs
CategoryPrescription Pharmaceuticals
Description

Generic prescription pharmaceuticals distributed to retail and hospital pharmacies, encompassing more than 60 SKUs across cardiovascular, neurological, psychiatric, anti-infective, metabolic, and other therapeutic categories, in forms including tablets, extended-release tablets, capsules, injectables, and oral solutions.

2OTC (Over-the-Counter) Products
CategoryOTC Pharmaceuticals
Description

Over-the-counter generic pharmaceutical products distributed to pharmacies, including analgesics, cold and cough medications, dermatological products, dental care products, and mineral supplements.

3Dietary Supplements
CategoryDietary Supplements
Description

Nutritional and dietary supplements distributed through pharmacies, including prenatal vitamins (WesTab, WesCaps, WesGel DHA, WesNate DHA, PNV 27), iron supplements (Ferrous Fumarate, Ferrous Gluconate, Ferrous Sulfate, Iron Folate Plus, Iron Polysaccharide Complex), phosphorus supplements (Wes-Phos 250 Neutral), and other vitamin and mineral supplements.

4Miglitol Tablets
CategoryPrescription Pharmaceuticals
Description

Single-source generic anti-diabetic medication (alpha-glucosidase inhibitor) for type 2 diabetes control, distributed in North America under partnership with OEP Pharma (US subsidiary of Orient Europharma Co., Ltd).

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-05-11
Description

Westminster Pharmaceuticals Scholarship established to help pharmacy students pursue education. Scholarship awarded to graduate students including Md Sakil Amin (Pharmaceutical Nanotechnology) and Yevgeny Habibe (first recipient Spring 2023).

2R&S Solutions (now Direct Customer Solutions)
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-03-03
Description

Preferred third-party logistics (3PL) provider for warehousing, distribution, and fulfillment. R&S Solutions operates a 230,000-square-foot state-of-the-art facility in West Tennessee with access to major freight routes and commercial airports. Partnership ensures on-time fulfillment with 100% accuracy.

wprx.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-12-14
Description

Partnership to distribute single-source generic drug miglitol. OEP Pharma (US subsidiary of Orient Europharma Co., Ltd) holds the only currently approved ANDA to miglitol and manufactures the product in Taiwan. Westminster oversees marketing and distribution in North America, enhancing patient access to the anti-diabetic medication.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

State-of-the-art fulfillment and distribution center featuring robotic technology, refrigeration capabilities, and enhanced security vault. Provides care, safety, and consistency for all products throughout the supply chain while preventing tampering.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1McKesson Corporation
TypeBroad incumbent
Description

Largest US pharmaceutical distributor, offering broad distribution, specialty, and biopharma services to pharmacies, hospitals, and manufacturers. Relevant as the dominant incumbent whose scale and reach Westminster competes against in the same customer segments.

TypeDirect peer
Description

Generic pharmaceutical distributor (a Teva subsidiary) supplying retail, hospital, and alternate-care customers in the US. Comparable to Westminster as a generic-led distributor that competes in the same mid-tier and specialty channels.

TypeDirect peer
Description

Specialty and generic pharmaceutical distributor serving independent and mid-chain pharmacies, hospitals, and clinics. Comparable to Westminster as a smaller competitor specializing in generic and specialty distribution to non-Big-3 channels.

TypeDirect peer
Description

Privately held, family-owned US pharmaceutical wholesaler specializing in branded, generic, and specialty distribution to independent and regional pharmacies. Closest comparable to Westminster in scale, customer type, and product mix (generic-led portfolio serving mid-market pharmacies).

TypeDirect peer
Description

Independent, member-owned pharmaceutical wholesaler serving independent pharmacies across the Northeast and nationally. Comparable to Westminster as a mid-sized generic and brand distributor focused on independent and community pharmacy customers.

TypeBroad incumbent
Description

Major US pharmaceutical and medical products distributor with both wholesale and at-Home Solutions businesses. Comparable to Westminster as a Big 3 wholesaler competing for the same retail and hospital pharmacy customers.

TypeDirect peer
Description

Regional pharmaceutical distributor serving independent pharmacies, hospitals, and long-term care facilities across the US. Comparable to Westminster as a mid-tier wholesaler competing on service quality and generics assortment against the Big 3.

TypeBroad incumbent
Description

Top-3 US pharmaceutical wholesaler serving retail, hospital, and manufacturer clients with global distribution and consulting services. Directly comparable as one of the Big 3 incumbents whose services overlap with Westminster's generic distribution offering.

TypeOthers
Description

Third-party logistics provider operating the 230,000 sq ft facility used by Westminster for warehousing and fulfillment. Relevant as Westminster's exclusive 3PL partner and as an ecosystem participant in the same pharmaceutical supply chain.

TypeDirect peer
Description

US pharmaceutical distributor and supply-chain services company focused on generics, OTC, and health-and-beauty products to retailers and wholesalers. Comparable to Westminster as an independent mid-market distributor with a multi-category generic and OTC portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Westminster Pharmaceuticals

Pharmaceutical Distributionwprx.com

Westminster Pharmaceuticals is a privately held US generic drug distributor (WPRX) serving retail and hospital pharmacies, wholesalers, and manufacturers with 100-plus prescription, OTC, and dietary supplement products.

What Westminster Pharmaceuticals does

Westminster Pharmaceuticals (operating commercially as WPRX) is a privately held B2B generic pharmaceutical distributor founded in 2012 and headquartered in Nashville, Tennessee, with a sales office in Tampa, Florida. The company distributes more than 100 generic pharmaceutical products across three categories (prescription drugs, over-the-counter medications, and dietary supplements) to retail and hospital pharmacies, wholesalers, distributors, and manufacturers across the United States. Named enterprise customers include Walgreens and Rite-Aid, and the company manages 180 Medicaid program contracts across all 50 states. Approximately 90 percent of products are manufactured domestically in the United States, which the company positions as a supply chain and quality differentiator against generic competitors reliant on offshore production.

The business operates a relationship-driven, sales-led go-to-market with named contacts for business development, sales, customer service, regulatory affairs, and pharmacovigilance. Underlying technology centers on SAP/ATTP serialization software for unit-level product tracking and DSCSA compliance (met ahead of the November 2024 stabilization deadline), supplemented by predictive analytics for demand forecasting. Fulfillment runs through Direct Customer Solutions (formerly R&S Solutions), a 230,000 sq ft third-party logistics facility in West Tennessee with robotic handling, refrigeration, and secured storage capabilities. The company does not sell directly to consumers and operates a quote-based B2B pricing model with no publicly disclosed pricing.

Westminster generates revenue from the margin between acquisition and sale prices on distributed generic pharmaceuticals (transaction-fee model), supplemented by manufacturer-side distribution partnerships. The company has executed strategic partnerships with OEP Pharma (single-source miglitol distribution) and the USF Taneja College of Pharmacy (industry scholarship), and was recognized with the USF Fast 56 Class of 2021 award and an EY Entrepreneur of the Year 2022 nomination for CEO Louis Sanchez. Under Sanchez's ownership since 2016, the company has reported an average of 400 percent year-over-year growth, operating with a small team of 11-50 employees.

Westminster Pharmaceuticals firmographics

Firmographics
Name
Westminster Pharmaceuticals
Legal name
Westminster Pharmaceuticals
Website
https://wprx.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Westminster Pharmaceuticals is a privately held US generic drug distributor (WPRX) serving retail and hospital pharmacies, wholesalers, and manufacturers with 100-plus prescription, OTC, and dietary supplement products.
Ownership category
akta.pro rank

Westminster Pharmaceuticals industry classification

Industry
Product category
Pharmaceutical Distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Generic pharmaceutical distribution
  • Pharmaceutical wholesale supply
  • Generic drug wholesale
  • Pharmaceutical logistics services
  • Generic medications supplier

Where Westminster Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Nashville
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Westminster Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Generic Pharmaceutical Distribution: Westminster Pharmaceuticals generates revenue by distributing generic drugs to pharmacies, hospitals, and trusted wholesalers and distributors. The company acquires high-quality generic drugs within high-demand categories and distributes them through its partner network, with revenue derived from the margin between acquisition and sale prices to B2B customers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Westminster Pharmaceuticals product offering

Product offering

Core offering

Westminster Pharmaceuticals distributes generic pharmaceutical products to retail pharmacies, hospital pharmacies, and authorized wholesalers and distributors across the United States. Its product portfolio spans prescription generic drugs (cardiovascular, neurological, psychiatric, anti-infective, metabolic, and other therapeutic categories), OTC products, and dietary supplements. Distribution and supply-chain operations are supported by a preferred 3PL partner and SAP/ATTP serialization technology for DSCSA-compliant traceability.

Product overview

Westminster Pharmaceuticals (WPRX) is a generic pharmaceutical distributor providing timely access to high-quality generic drugs at affordable prices. The company's product portfolio consists of three main categories distributed through pharmacies, hospitals, and wholesalers: Prescription Generic Drugs (including extended-release formulations, injectables, and oral solutions across cardiovascular, neurological, psychiatric, anti-infective, metabolic, and other therapeutic categories), OTC Products (including analgesics, cold/cough medications, dermatological products, dental care products, and mineral supplements), and Dietary Supplements (including prenatal vitamins, iron supplements, and phosphorus supplements for dialysis patients). The portfolio includes branded product lines such as WesTussin cough liquids, WesTab/WesCaps/WesGel/WesNate prenatal supplements, and Wes-Phos phosphorus supplements. Nearly 90% of products are manufactured in the United States.

Differentiator

Problem solved

Functional benefit

Brands

  • WPRX: Primary commercial brand name and website domain for Westminster Pharmaceuticals generic pharmaceutical distribution.

Products and services

  • Prescription Generic Drugs Generic prescription pharmaceuticals distributed to retail and hospital pharmacies, encompassing more than 60 SKUs across cardiovascular, neurological, psychiatric, anti-infective, metabolic, and other therapeutic categories, in forms including tablets, extended-release tablets, capsules, injectables, and oral solutions.
  • OTC (Over-the-Counter) Products Over-the-counter generic pharmaceutical products distributed to pharmacies, including analgesics, cold and cough medications, dermatological products, dental care products, and mineral supplements.
  • Dietary Supplements Nutritional and dietary supplements distributed through pharmacies, including prenatal vitamins (WesTab, WesCaps, WesGel DHA, WesNate DHA, PNV 27), iron supplements (Ferrous Fumarate, Ferrous Gluconate, Ferrous Sulfate, Iron Folate Plus, Iron Polysaccharide Complex), phosphorus supplements (Wes-Phos 250 Neutral), and other vitamin and mineral supplements.
  • Miglitol Tablets Single-source generic anti-diabetic medication (alpha-glucosidase inhibitor) for type 2 diabetes control, distributed in North America under partnership with OEP Pharma (US subsidiary of Orient Europharma Co., Ltd).

Quantifiable outcome

  • 400% average annual growth since 2016 new ownership
  • +2 more outcomes

Companies that use Westminster Pharmaceuticals

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Westminster Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Westminster Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor and core.

  • University of South Florida Taneja College of PharmacyminorStrategic or Co-development Partner · 11 May 2021Westminster Pharmaceuticals Scholarship established to help pharmacy students pursue education. Scholarship awarded to graduate students including Md Sakil Amin (Pharmaceutical Nanotechnology) and Yevgeny Habibe (first recipient Spring 2023).
  • R&S Solutions (now Direct Customer Solutions)coreChannel Partner/ Reseller/ Distributor · 3 March 2021Preferred third-party logistics (3PL) provider for warehousing, distribution, and fulfillment. R&S Solutions operates a 230,000-square-foot state-of-the-art facility in West Tennessee with access to major freight routes and commercial airports. Partnership ensures on-time fulfillment with 100% accuracy.
  • OEP PharmacoreChannel Partner/ Reseller/ Distributor · 14 December 2020Partnership to distribute single-source generic drug miglitol. OEP Pharma (US subsidiary of Orient Europharma Co., Ltd) holds the only currently approved ANDA to miglitol and manufactures the product in Taiwan. Westminster oversees marketing and distribution in North America, enhancing patient access to the anti-diabetic medication.
  • Direct Customer Solutions (formerly R&S Solutions)coreChannel Partner/ Reseller/ DistributorState-of-the-art fulfillment and distribution center featuring robotic technology, refrigeration capabilities, and enhanced security vault. Provides care, safety, and consistency for all products throughout the supply chain while preventing tampering.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Westminster Pharmaceuticals competitors and assessment

Company assessment

Broad incumbents

  • McKesson Corporation: Largest US pharmaceutical distributor, offering broad distribution, specialty, and biopharma services to pharmacies, hospitals, and manufacturers. Relevant as the dominant incumbent whose scale and reach Westminster competes against in the same customer segments.
  • Cardinal Health: Major US pharmaceutical and medical products distributor with both wholesale and at-Home Solutions businesses. Comparable to Westminster as a Big 3 wholesaler competing for the same retail and hospital pharmacy customers.
  • Cencora (formerly AmerisourceBergen): Top-3 US pharmaceutical wholesaler serving retail, hospital, and manufacturer clients with global distribution and consulting services. Directly comparable as one of the Big 3 incumbents whose services overlap with Westminster's generic distribution offering.

Direct peers

  • Anda, Inc. Generic pharmaceutical distributor (a Teva subsidiary) supplying retail, hospital, and alternate-care customers in the US. Comparable to Westminster as a generic-led distributor that competes in the same mid-tier and specialty channels.
  • Masters Pharmaceutical: Specialty and generic pharmaceutical distributor serving independent and mid-chain pharmacies, hospitals, and clinics. Comparable to Westminster as a smaller competitor specializing in generic and specialty distribution to non-Big-3 channels.
  • Morris & Dickson Co. Privately held, family-owned US pharmaceutical wholesaler specializing in branded, generic, and specialty distribution to independent and regional pharmacies. Closest comparable to Westminster in scale, customer type, and product mix (generic-led portfolio serving mid-market pharmacies).
  • Rochester Drug Cooperative: Independent, member-owned pharmaceutical wholesaler serving independent pharmacies across the Northeast and nationally. Comparable to Westminster as a mid-sized generic and brand distributor focused on independent and community pharmacy customers.
  • Smith Drug Company: Regional pharmaceutical distributor serving independent pharmacies, hospitals, and long-term care facilities across the US. Comparable to Westminster as a mid-tier wholesaler competing on service quality and generics assortment against the Big 3.
  • Quality King Distributors: US pharmaceutical distributor and supply-chain services company focused on generics, OTC, and health-and-beauty products to retailers and wholesalers. Comparable to Westminster as an independent mid-market distributor with a multi-category generic and OTC portfolio.

Others

  • Direct Customer Solutions (R&S Solutions): Third-party logistics provider operating the 230,000 sq ft facility used by Westminster for warehousing and fulfillment. Relevant as Westminster's exclusive 3PL partner and as an ecosystem participant in the same pharmaceutical supply chain.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Westminster Pharmaceuticals social profiles

Digital presence

Westminster Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Westminster Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles9 records

Westminster Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Westminster Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Westminster Pharmaceuticals

What does Westminster Pharmaceuticals do?

Westminster Pharmaceuticals distributes generic pharmaceutical products to retail pharmacies, hospital pharmacies, and authorized wholesalers and distributors across the United States. Its product portfolio spans prescription generic drugs (cardiovascular, neurological, psychiatric, anti-infective, metabolic, and other therapeutic categories), OTC products, and dietary supplements. Distribution and supply-chain operations are supported by a preferred 3PL partner and SAP/ATTP serialization technology for DSCSA-compliant traceability.

Is Westminster Pharmaceuticals a public or private company?

Westminster Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Westminster Pharmaceuticals founded?

Westminster Pharmaceuticals was founded in 2012. It employs 11 to 50 people.

Where is Westminster Pharmaceuticals based?

Westminster Pharmaceuticals is headquartered in Nashville, United States, in the North America region.

How does Westminster Pharmaceuticals make money?

One revenue line is on record: generic Pharmaceutical Distribution.

Who are Westminster Pharmaceuticals's main competitors?

Broad incumbents on record are McKesson Corporation, Cardinal Health and Cencora (formerly AmerisourceBergen). Direct peers are Anda, Inc., Masters Pharmaceutical, Morris & Dickson Co., Rochester Drug Cooperative, Smith Drug Company and Quality King Distributors. Direct Customer Solutions (R&S Solutions) is listed as an others.

Does Westminster Pharmaceuticals have an API?

No public API is recorded for Westminster Pharmaceuticals.

What industry is Westminster Pharmaceuticals in?

Westminster Pharmaceuticals's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WprxPharmaceutical partnerships: bridging gaps in the supply chain — WPRXWestminster Pharmaceuticals (WPRX) is emphasizing its commitment to collaboration within the generic pharmaceutical sector to improve supply chain efficiency and patient access. The company will have its Head of Business Development, Jonathan Olive, attend CPHI Milan from October 8-10th to connect with industry peers and potential partners.WprxNext-Gen Generics: Complex Drug Formulations — WPRXThe article examines the growing role of complex generic drug formulations, such as extended-release tablets and inhalers, which are reshaping the pharmaceutical industry by offering advanced treatment options for chronic conditions. It highlights how technological advancements in nanotechnology, 3D printing, and lipid-based systems are improving bioavailability and patient adherence while facing regulatory hurdles. Westminster Pharmaceuticals is identified as a key player committed to collaborating with stakeholders to expand access to these next-generation generics.WprxTelemedicine: Elevate your online pharmacy with generic drugs — WPRXThe article promotes Westminster Pharmaceuticals (WPRX) as a supplier of generic medications for online pharmacies leveraging telemedicine services. It highlights the growth of the telehealth market and argues that integrating WPRX's affordable, high-quality generics can enhance accessibility and cost-effectiveness for patients.WprxSupply Chain Synergy: The Benefits of our Seamless Generic Drug Distribution — WPRXWestminster Pharmaceuticals published a promotional overview of its generic drug distribution services, covering planning, procurement, distribution, compliance and sales and marketing support. The company cites FDA registration, CFR 210/211 audits, serialization and DSCSA compliance, and private labeling. It partners with 3PL provider Direct Customer Solutions for warehousing and fulfillment.WprxThe Future of Generic Pharmaceuticals: Innovations and Trends — WPRXA Westminster Pharmaceuticals article outlines emerging trends in the generic pharmaceutical market, including complex generics, biosimilars, pharmacogenomics, and telepharmacy. It notes generics fill 9 of 10 prescriptions but account for only 18.2% of drug spend, costing 80-85% less than branded drugs, and projects the global market exceeding $682.9 billion by 2030.WprxManufacturing Generic Drugs in the US: What You Need to Know — WPRXA promotional piece from Westminster Pharmaceuticals explains how generic drugs are manufactured and approved in the US, noting that about 89% of US prescriptions are for generics, which cost under $20 in 90% of cases. It states the company manufactures nearly 90% of its products domestically, while the supply chain captures roughly 64% of generic revenue versus 76% for branded makers.WprxUnderstanding the Pharmaceutical Supply Chain — WPRXThe article explains the pharmaceutical supply chain, outlining its three main steps: manufacturing by branded, generic and specialty makers; transfer to wholesalers and distributors; and delivery to providers such as retail, specialty and mail-order pharmacies and hospitals. It notes additional participants including insurers, PBMs and research firms, and promotes Westminster Pharmaceuticals as a manufacturer supplying wholesalers.PR NewswirePreliminary Approval Granted In Class Action Settlement Involving Recipients of Facsimile Advertisements from Trxade Group, Inc. and Westminster Pharmaceuticals, LLCThe United States District Court for the Southern District of Alabama granted preliminary approval to a proposed settlement in a class action lawsuit against Trxade Group, Inc. and Westminster Pharmaceuticals, LLC. The lawsuit alleged violations of the Telephone Consumer Protection Act for sending unsolicited fax advertisements without proper opt-out notices and without prior express consent during the period of January 1, 2012 to November 4, 2016. Under the settlement terms, the defendants will pay $200,000 into a Settlement Fund to be distributed to class members who submit valid claims, with individual claimants eligible to receive up to $1,000 each on a pro rata basis.GlobeNewswireTrxade Group, Inc. Launches HCTZ (Hydrochlorothiazide) to Treat Fluid EdemaTrxade Group's subsidiary Westminster Pharmaceuticals launched generic HCTZ (hydrochlorothiazide) under an exclusive agreement with ScieGen Pharmaceuticals. The drug treats fluid retention in conditions like congestive heart failure and hypertension, and Westminster will semi-exclusively market it in the U.S. The launch is part of Trxade's expansion, with its trading platform having surpassed 5,000 members.GlobeNewswireTrxade Group Signs Agreement to Distribute Glaucoma Drug in U.S.Trxade Group's subsidiary Westminster Pharmaceuticals launched Brimonidine Tartrate Ophthalmic Solution 0.2% under an exclusive agreement with Indoco Remedies. The drug, for glaucoma, generated about $6.8 million in 2014 sales, and Westminster will distribute it in the U.S. starting this quarter. The agreement runs until 2022.